Skip to main content

RIG-I Products

RIG-I-like Receptors (RLRs) are a subset of cytosolic pattern recognition receptors that are essential for antiviral immunity. The RLR family consists of three members: RIG-I, MDA5, and LGP2. Unlike the NOD-like Receptor (NLR) family proteins, the RLR proteins are RNA helicases that recognize viral RNA. RIG-I and MDA5 contain two N-terminal caspase recruitment domains (CARDs), an internal RNA helicase domain, and a C-terminal repressor/RNA-binding domain. Signaling through both receptors activates NF-kappa B- and IRF3-/IRF7-dependent gene expression, leading to the secretion of pro-inflammatory cytokines, and type I and type III interferons, respectively. Unlike RIG-I and MDA5, LGP2 does not contain a CARD domain at its N-terminal end and has not been shown to bind to RNA. As a result, LGP2 is currently thought to serve as a regulator of RIG-I and MDA5 signaling.

Show More

96 results for "RIG-I" in Products

Back to Search Results
Apply

96 results for "RIG-I" in Products

RIG-I Products

RIG-I-like Receptors (RLRs) are a subset of cytosolic pattern recognition receptors that are essential for antiviral immunity. The RLR family consists of three members: RIG-I, MDA5, and LGP2. Unlike the NOD-like Receptor (NLR) family proteins, the RLR proteins are RNA helicases that recognize viral RNA. RIG-I and MDA5 contain two N-terminal caspase recruitment domains (CARDs), an internal RNA helicase domain, and a C-terminal repressor/RNA-binding domain. Signaling through both receptors activates NF-kappa B- and IRF3-/IRF7-dependent gene expression, leading to the secretion of pro-inflammatory cytokines, and type I and type III interferons, respectively. Unlike RIG-I and MDA5, LGP2 does not contain a CARD domain at its N-terminal end and has not been shown to bind to RNA. As a result, LGP2 is currently thought to serve as a regulator of RIG-I and MDA5 signaling.

Show More
Applications: WB
Reactivity: Human
Applications: IHC, WB
Reactivity: Human, Primate
Applications: IHC, WB, ELISA, ICC/IF
Reactivity: Human, Mouse, Rat
Applications: WB, ELISA, ICC/IF, Flow
Reactivity: Human
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: WB, ELISA, MA, AP, PAGE
Applications: IHC, WB, IP
Reactivity: Human, Mouse
Applications: AC
Applications: ICC/IF
Reactivity: Human
Applications: WB, ICC/IF, KO
Reactivity: Human, Mouse
Applications: IHC
Reactivity: Human
Applications: WB, IP
Reactivity: Human

Recombinant Monoclonal Antibody

Applications: IHC, ELISA
Reactivity: Human

Recombinant Monoclonal Antibody

Applications: WB, ELISA
Reactivity: Human, Mouse
Applications: WB, ELISA
Reactivity: Human
Applications: WB, ELISA
Reactivity: Human, Rat
Applications: IHC, WB, IP
Reactivity: Human, Mouse
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: IHC, WB
Reactivity: Human, Primate
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: IHC, WB, ICC/IF
Reactivity: Human
Applications: IHC, WB, IP
Reactivity: Human, Mouse
Results Per Page
5 10 25 50
/ 4